NBTX vs NEUP

Nanobiotix S.A. vs Neuphoria Therapeutics Inc. — Valuation Comparison 2026

NBTX

Biotechnology
Nanobiotix S.A.
Quality
5.0
out of 10
Value Trap
18
SAFE
Price
$40.41
Last close
Models
6/13
Active
VS

NEUP

Biotechnology
Neuphoria Therapeutics Inc.
Quality
5.4
out of 10
Value Trap
6
SAFE
Price
$5.36
Last close
Models
10/13
Active

Model-by-Model Comparison

ModelType NBTX Fair ValueNBTX Upside NEUP Fair ValueNEUP Upside
Bayesian DCF Intrinsic $9.06 -77.6% $3.75 -30.0%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $5.64 -86.0% $0.61 -88.6%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $40.14 -0.7% $6.04 +12.6%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for NBTX vs NEUP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NBTX vs NEUP — Which Stock Is More Undervalued?

NEUP scores higher with a 5.4/10 quality rating vs NBTX's 5.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Nanobiotix S.A. (NBTX) and Neuphoria Therapeutics Inc. (NEUP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NBTX currently trades at $40.41 with a QOC of 5.0/10, while NEUP trades at $5.36 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).